101 related articles for article (PubMed ID: 26242142)
1. [CURRENT STATE OF COMBINED TREATMENT FOR LOCALLY ADVANCED GASTRIC CANCER. ACHIEVEMENTS AND FAILURES: BASIC TRENDS IN CLINICAL ONCOLOGY].
Ter-Ovanesov MD; Fatuev OE; Gaboyan AS; Levitsky AV; Lesnidze EE; Baksiyan GA; Valkin DL
Vopr Onkol; 2015; 61(3):329-38. PubMed ID: 26242142
[TBL] [Abstract][Full Text] [Related]
2. Gastric cancer in the elderly: an overview.
Saif MW; Makrilia N; Zalonis A; Merikas M; Syrigos K
Eur J Surg Oncol; 2010 Aug; 36(8):709-17. PubMed ID: 20542657
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis.
Tsuburaya A; Mizusawa J; Tanaka Y; Fukushima N; Nashimoto A; Sasako M;
Br J Surg; 2014 May; 101(6):653-60. PubMed ID: 24668391
[TBL] [Abstract][Full Text] [Related]
4. [Multimodal therapy in locally advanced gastric cancer].
Bölke E; Peiper M; Knoefel WT; Baldus SE; Schauer M; Matuschek C; Gerber PA; Hoff NP; Budach W; Gattermann N; Erhardt A; Scherer A; Buhren BA; Orth K
Dtsch Med Wochenschr; 2011 Oct; 136(43):2205-11. PubMed ID: 22009175
[TBL] [Abstract][Full Text] [Related]
5. Current status and future perspectives in gastric cancer management.
Roukos DH
Cancer Treat Rev; 2000 Aug; 26(4):243-55. PubMed ID: 10913380
[TBL] [Abstract][Full Text] [Related]
6. Treatment of locally advanced gastric cancer with the XELOX program of neoadjuvantchemotherapy combined with laparoscopic surgery: the experience in China.
Zheng CH; Lu J; Huang CM; Li P; Xie JW; Wang JB; Lin JX
Hepatogastroenterology; 2014 Oct; 61(135):1876-82. PubMed ID: 25713882
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of pre-operative chemotherapy with docetaxel, cisplatin, and S-1 (DCS therapy) and curative resection for gastric cancer with pathologically positive para-aortic lymph nodes.
Oyama K; Fushida S; Kinoshita J; Makino I; Nakamura K; Hayashi H; Nakagawara H; Tajima H; Fujita H; Takamura H; Ninomiya I; Kitagawa H; Tani T; Fujimura T; Ohta T
J Surg Oncol; 2012 May; 105(6):535-41. PubMed ID: 22006649
[TBL] [Abstract][Full Text] [Related]
8. Phase II trial of preoperative S-1 plus cisplatin followed by surgery for initially unresectable locally advanced gastric cancer.
Inoue K; Nakane Y; Kogire M; Fujitani K; Kimura Y; Imamura H; Tamura S; Okano S; Kwon AH; Kurokawa Y; Shimokawa T; Takiuchi H; Tsujinaka T; Furukawa H
Eur J Surg Oncol; 2012 Feb; 38(2):143-9. PubMed ID: 22154885
[TBL] [Abstract][Full Text] [Related]
9. The multidisciplinary management of gastrointestinal cancer. Multimodal treatment of gastric cancer.
Moehler M; Galle PR; Gockel I; Junginger T; Schmidberger H
Best Pract Res Clin Gastroenterol; 2007; 21(6):965-81. PubMed ID: 18070698
[TBL] [Abstract][Full Text] [Related]
10. Prediction of response and prognosis by a score including only pretherapeutic parameters in 410 neoadjuvant treated gastric cancer patients.
Lorenzen S; Blank S; Lordick F; Siewert JR; Ott K
Ann Surg Oncol; 2012 Jul; 19(7):2119-27. PubMed ID: 22395980
[TBL] [Abstract][Full Text] [Related]
11. Advanced gastric cancer: What we know and what we still have to learn.
Coccolini F; Montori G; Ceresoli M; Cima S; Valli MC; Nita GE; Heyer A; Catena F; Ansaloni L
World J Gastroenterol; 2016 Jan; 22(3):1139-59. PubMed ID: 26811653
[TBL] [Abstract][Full Text] [Related]
12. Prognostic indicators in locally advanced gastric cancer (LAGC) treated with preoperative chemotherapy and D2-gastrectomy.
Persiani R; D'Ugo D; Rausei S; Sermoneta D; Barone C; Pozzo C; Ricci R; La Torre G; Picciocchi A
J Surg Oncol; 2005 Mar; 89(4):227-36; discussion 237-8. PubMed ID: 15726615
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of intraoperative chemotherapy and extensive lymphadenectomy in patients with node-negative gastric cancer.
Wang J; Yu JC; Kang WM; Ma ZQ
J Surg Oncol; 2012 Mar; 105(4):400-4. PubMed ID: 22311818
[TBL] [Abstract][Full Text] [Related]
14. The relationship between improved prognosis in gastric cancer patients in the last 25 years and changing methods of surgical and combined treatment.
Popiela T; Kulig J; Kołodziejczyk P;
Przegl Lek; 2000; 57 Suppl 5():9-13. PubMed ID: 11202309
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up of a pilot phase II study with neoadjuvant epidoxorubicin, etoposide and cisplatin in gastric cancer.
Barone C; Cassano A; Pozzo C; D'Ugo D; Schinzari G; Persiani R; Basso M; Brunetti IM; Longo R; Picciocchi A
Oncology; 2004; 67(1):48-53. PubMed ID: 15459495
[TBL] [Abstract][Full Text] [Related]
16. [Locally advanced or metastatic gastric cancer--new therapeutic solutions].
Pătraşcu F; Croitoru A; Gramaticu I; Andrei M; Teiuţanu A; Diculescu M
Rev Med Chir Soc Med Nat Iasi; 2011; 115(1):20-6. PubMed ID: 21688555
[TBL] [Abstract][Full Text] [Related]
17. Low creatinine clearance is a risk factor for D2 gastrectomy after neoadjuvant chemotherapy.
Hayashi T; Aoyama T; Tanabe K; Nishikawa K; Ito Y; Ogata T; Cho H; Morita S; Miyashita Y; Tsuburaya A; Sakamoto J; Yoshikawa T
Ann Surg Oncol; 2014 Sep; 21(9):3015-22. PubMed ID: 24715213
[TBL] [Abstract][Full Text] [Related]
18. [Current status and prospect of perioperative therapy for locally advanced gastric cancer].
Zhu ZG
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):101-106. PubMed ID: 33508913
[TBL] [Abstract][Full Text] [Related]
19. Combination 5-fluoruracil/cisplatinum versus 5-fluoruracil/leucovorin adjuvant chemotherapy efficacy for R0 gastric resection in locally invasive gastric cancer.
Yamada S; Ritchim P; Charkrabandhu T; Jongraksat W
J Med Assoc Thai; 2012 Dec; 95(12):1517-23. PubMed ID: 23390781
[TBL] [Abstract][Full Text] [Related]
20. [Total gastrectomy for gastric cancer: can the type of lymphadenectomy condition the long-term results?].
Di Martino N; Izzo G; Cosenza A; Vicenzo L; Monaco L; Torelli F; Basciotti A; Brillantino A; Marra A
Suppl Tumori; 2005; 4(3):S84-5. PubMed ID: 16437920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
